Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof

Details for Australian Patent Application No. 2007282923 (hide)

Owner Roche GlycArt AG

Inventors Mossner, Ekkehard; Umana, Pablo

Agent Davies Collison Cave

Pub. Number AU-B-2007282923

PCT Pub. Number WO2008/017963

Priority 60/836,371 09.08.06 US

Filing date 9 August 2007

Wipo publication date 14 February 2008

Acceptance publication date 13 September 2012

International Classifications

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

5 March 2009 PCT application entered the National Phase

  PCT publication WO2008/017963 Priority application(s): WO2008/017963

23 August 2012 Alteration of Name

  The name of the applicant has been altered to Roche GlycArt AG

13 September 2012 Application Accepted

  Published as AU-B-2007282923

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007282949-(3-amino-1,2,3,4-tetrahydro-9H-carbazol-9-YL)-acetic acid derivatives

2007282922-Microcapsules with improved shells